Clinical pregnancy rate · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
Clomiphene citrate or letrozole with or without gonadotropins (with… showed no clear difference in clinical pregnancy rate per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).
1 finding from 1 review
Cancellation rate per woman · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
Clomiphene citrate or letrozole with or without gonadotropins (with… may leads to higher cancellation rate per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).
1 finding from 1 review
Live birth rate · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ongoing pregnancy · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in ongoing pregnancy rate compared with placebo/no treatment (low certainty).
1 finding from 1 review
Miscarriage per clinical pregnancy · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in miscarriage rate per clinical pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
Progesterone may leads to higher clinical pregnancy rate compared with placebo/no treatment (low certainty).
1 finding from 1 review
Multiple pregnancy rate · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in multiple pregnancy rate compared with placebo/no treatment (low certainty).
1 finding from 1 review
Adverse events, OHSS, preterm delivery, congenital anomaly · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth or ongoing pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in live birth rate/ongoing pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Miscarriage per clinical pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in miscarriage rate per clinical pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Clinical pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone may leads to higher clinical pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Multiple pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in multiple pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Adverse events, OHSS, preterm delivery, congenital anomaly · women with oral (clomiphene citrate or letrozole) stimulation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Seizure freedom (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy
The intervention showed no clear difference in seizure freedom (1‐ to 3‐month blinded evaluation periods) (moderate certainty).
1 finding from 1 review
Intervention not reported
Responder rate (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy
The intervention showed no clear difference in responder rate (1‐ to 3‐month blinded evaluation periods) (low certainty).
1 finding from 1 review
Intervention not reported
Seizure frequency (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
Intervention not reported
Adverse events · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
Intervention not reported
Neuropsychological outcome (1‐ to 3‐month periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
Intervention not reported
Quality of life (QOLIE‐89) (1‐ to 3‐month periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
no estimate extracted
1 study · 3 participants
Very low